AngioDynamics, Inc.
AngioDynamics, Inc.
ANGO
Valuace
70
Růst
0
Zdraví
65
Cena
$ 12.35
Dnes
--0.56 (-5.09%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.5B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-16
PS
1
Cena 1R
8-14
⌀ Cena
10.63
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
01-04-2026
Poslední dividenda

Profil

Společnost AngioDynamics, Inc. navrhuje, vyrábí a prodává různé lékařské, chirurgické a diagnostické přístroje používané profesionálními poskytovateli zdravotní péče pro léčbu onemocnění periferních cév a přístupu k cévám; a pro použití v onkologii a chirurgickém prostředí ve Spojených státech a mezinárodně. Společnost poskytuje NanoKnife ablační systémy pro chirurgickou ablaci měkkých tkání, solero mikrovlnné tkáňové ablační systémy a produkty radioffrekvenční ablace pro ablaci solidních rakovinných nebo nezhoubných nádorů. Nabízí také těsnící systémy BioSentry, balónek IsoLoc Endorectal, balónové balónky alatus vaginal, angiografické katétry, vodicí dráty, koaxiální mikrozaváděcí soupravy pro perkutánní odvodnění. Kromě toho společnost poskytuje produkty endovaskulární terapie v oblastech trombu řízení, ektomie, periferních produktů (Core) a žilní nedostatečnosti. Kromě toho společnost nabízí periferně vložené centrální katétry, midline katétry, implantabilní porty, dialyzační katétry a související doplňky a potřeby, které jsou primárně využívány k dodávání krátkodobých lékových terapií, jako jsou chemoterapeutika a antibiotika, do centrálního žilního systému pod názvy BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax a DuraMax. Prodává své produkty intervenčním radiologům, intervenčním kardiologům, vaskulárním chirurgům, urologům, intervenčním a chirurgickým onkologům a zdravotním sestrám v kritické péči přímo, jakož i prostřednictvím distributorských vztahů. Společnost byla založena v roce 1988 a sídlí v Lathamu v New Yorku.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
748
Založení
2004-06-01
Adresa
14 Plaza Drive
CEO
James C. Clemmer

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues307.3292.5303.9338.8316.2291.0264.2359.5344.3349.6353.7357.0354.5342.0221.8216.0216.0
Cost of Revenues142.2134.8149.2164.5150.5134.2113.9167.6167.4173.5179.7180.1174.6173.095.890.189.1
Gross Profit165.1157.7154.7174.2165.7156.8150.3191.9176.9176.2174.0176.9179.9169.0126.0125.8127.0
Revenue 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Total Revenues79.475.780.272.072.867.571.075.279.178.7
Cost of Revenues37.333.937.933.132.930.832.539.338.838.6
Gross Profit42.141.942.238.939.936.738.535.940.340.1
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.029.930.736.429.729.425.525.325.126.927.526.320.521.419.3
Selling General & Admin Expenses0.00.00.0144.3133.8117.2116.5116.1108.5110.2114.1110.5109.2102.282.876.077.4
Depreciation & Amortization24.025.827.733.229.325.923.825.923.224.828.430.525.129.113.012.612.5
Total Operating Expenses194.0197.7347.1192.9183.9171.8164.3165.3150.6151.0159.8159.5157.4146.7112.8106.6106.1
Operating Income-28.9-40.0-192.4-19.2-19.0-14.9-14.221.410.615.00.7-1.013.47.1-3.012.120.9
Operating Income TTM 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
R&D Expenses0.00.00.00.00.00.00.00.00.00.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.00.00.0
Depreciation & Amortization5.86.05.86.36.96.86.87.56.76.7
Total Operating Expenses44.652.548.048.851.049.853.0235.853.45.0
Operating Income-2.5-10.7-5.8-10.0-11.1-13.1-14.4-199.9-13.135.0
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.11.01.62.70.00.00.00.00.00.00.00.00.00.11.10.70.7
Interest Expense0.10.00.02.70.70.90.95.13.12.83.43.23.75.30.50.50.7
Other Expense1.25.90.8-35.2-10.9-21.2-153.0-13.5-15.7-13.4-18.5-25.4-16.1-22.9-18.5-8.4-1.3
IBT-27.7-34.0-191.6-54.4-29.9-36.1-167.159.57.511.8-4.4-8.06.4-0.6-5.310.819.6
Income Tax Expense0.00.0-7.3-2.0-3.4-4.5-1.3-1.9-8.94.840.1-4.73.30.0-0.22.67.3
Net Income-27.7-34.0-184.3-52.4-26.5-31.5-165.861.316.37.0-44.5-3.33.1-0.6-5.18.212.3
Net Income TTM 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Interest Income0.00.00.00.10.20.60.60.40.50.1
Interest Expense0.10.00.00.00.00.00.00.00.00.0
Other Expense-3.9-0.2-0.35.60.20.40.30.20.5-0.2
IBT-6.4-10.8-6.1-4.4-10.8-12.7-14.1-199.7-12.634.9
Income Tax Expense0.00.1-0.10.0-0.10.1-0.7-12.016.4-11.0
Net Income-6.4-10.9-6.1-4.4-10.7-12.8-13.4-187.7-29.045.9
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-1.33$-0.68$-0.82$-4.37$1.64$0.44$0.19$-1.23$-0.09$0.09$-0.02$-0.20$0.33$0.50
EPS Diluted$0.00$0.00$0.00$-1.33$-0.68$-0.82$-4.37$1.64$0.44$0.19$-1.23$-0.09$0.09$-0.02$-0.20$0.33$0.50
Shares Outstanding41.441.040.239.539.038.338.037.537.136.636.235.735.134.825.424.924.6
Diluted Shares Outstanding41.441.040.239.539.038.338.037.537.537.036.235.735.434.825.425.124.8
Per Share Data TTM 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Shares Outstanding41.441.241.040.940.940.740.440.240.239.8
Diluted Shares Outstanding41.441.241.040.940.940.740.440.240.240.0
Current Assets TTM 2025202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents76.155.976.144.628.848.254.4227.674.147.532.318.416.121.823.546.058.8
Short Term Investments0.00.00.00.00.00.00.00.01.31.21.71.71.82.214.185.641.3
Total Cash & ST Investments76.155.976.144.628.848.254.4227.675.448.834.020.117.924.037.6131.5100.1
Accounts Receivable43.643.150.052.852.335.431.343.639.444.552.958.462.248.151.127.429.8
Inventory60.662.060.655.351.448.659.940.148.954.555.467.461.155.155.828.129.2
Other Current Assets13.07.36.610.82.21.82.22.22.52.82.19.911.11.014.77.512.2
Total Current Assets193.3168.3193.3163.5143.3140.9152.9315.3168.0153.9146.3155.8152.2141.6159.3194.4171.4
Current Assets 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Cash And Equivalents38.855.944.854.155.076.178.560.957.644.6
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments38.855.944.854.155.076.178.560.957.644.6
Accounts Receivable42.643.149.043.239.650.049.551.649.852.8
Inventory62.362.063.165.964.760.658.164.360.055.3
Other Current Assets13.07.315.412.213.36.610.98.78.210.8
Total Current Assets156.7168.3172.3175.4172.6193.3196.9185.5175.5163.5
Long-Term Assets TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment41.532.335.744.445.037.128.324.342.545.248.354.667.262.755.923.824.2
Goodwill0.00.00.0159.2201.1201.3201.5347.7361.3361.3361.3361.3360.3355.4314.0162.0162.0
Intangible Assets77.469.177.4111.1152.4169.0197.1145.4130.3145.7167.6181.8205.3214.8143.648.058.4
Long-Term Investments-4.90.00.0-12.80.0-20.0-24.1-14.5-17.2-26.1-21.70.00.00.00.00.00.0
Other Long-Term Assets5.610.411.454.3-5.113.215.63.83.41.94.75.35.46.111.93.55.5
Total Long-Term Assets124.4111.8124.4369.1409.4420.6442.6521.1537.4554.0581.8617.8647.9650.3565.8243.1252.6
Total Assets317.7280.1317.7532.6552.8561.4595.5836.4705.5708.0728.1773.6800.2791.9725.1437.5423.9
Long-Term Assets 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Property, Plant & Equipment31.132.332.533.034.435.737.042.643.444.4
Goodwill0.00.00.00.00.00.00.0159.2159.0159.2
Intangible Assets68.469.170.973.175.877.481.6103.9106.7111.1
Long-Term Investments0.00.00.00.00.00.00.00.00.0-12.8
Other Long-Term Assets9.510.49.710.110.911.49.38.59.454.3
Total Long-Term Assets109.0111.8113.1116.2121.0124.4127.9314.2318.5369.1
Total Assets265.6280.1285.4291.6293.6317.7324.8499.6493.9532.6
Current Liabilities TTM 2025202420232022202120202019201820172016201520142013201220112010
Accounts Payable37.833.337.840.428.019.619.122.815.818.115.623.732.924.529.211.412.0
Short-Term Debt2.00.04.71.98.80.00.812.17.114.629.218.721.316.77.50.30.3
Other Current Liabilities51.442.948.241.021.538.02.138.32.19.612.910.017.820.919.325.225.8
Current Liabilities91.276.291.283.874.357.651.573.357.369.567.161.272.263.759.225.526.0
Current Liabilities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Accounts Payable31.933.330.334.731.337.835.237.724.840.4
Short-Term Debt0.00.05.05.04.84.70.00.04.71.9
Other Current Liabilities36.442.941.748.039.748.250.239.826.341.0
Current Liabilities68.376.278.088.676.791.285.978.057.583.8
Long-Term Liabilities TTM 2025202420232022202120202019201820172016201520142013201220112010
Long-Term Debt3.90.00.053.125.020.040.0124.486.691.3105.2128.9137.7135.0142.56.36.6
Capital Leases3.93.93.93.30.00.00.00.00.00.00.00.00.00.00.00.00.0
Def. Tax Liability4.94.14.912.816.020.024.114.517.226.121.71.11.111.039.25.82.5
Total Liabilities112.197.2112.1154.3128.3122.0139.6221.6162.9190.9221.0228.6262.3265.1201.731.832.6
Long-Term Liabilities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Long-Term Debt0.00.00.00.00.00.00.00.00.053.1
Capital Leases0.03.90.00.05.43.92.32.62.93.3
Def. Tax Liability4.34.14.24.34.64.95.917.81.312.8
Total Liabilities86.897.299.5104.897.0112.1106.198.466.1154.3
Total Common Equity TTM 2025202420232022202120202019201820172016201520142013201220112010
Common Stock0.40.40.40.40.40.40.40.40.40.40.40.40.40.40.30.30.2
Retained Earnings-395.2-429.2-395.2-210.9-158.4-131.9-100.366.55.1-11.0-16.028.232.729.630.235.327.2
Comprehensive Income-4.4-2.0-4.4-4.71.43.2-1.3-1.4-1.0-1.3-0.8-1.6-1.3-1.5-1.3-1.3-1.4
Total Common Equity205.6183.0205.6378.3424.5439.5455.9614.8542.6517.0507.0545.0537.9526.8523.4405.7391.3
Total Common Equity 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Common Stock0.40.40.40.40.40.40.40.40.40.4
Retained Earnings-440.1-429.2-423.1-418.7-408.0-395.2-381.8-194.0-165.0-210.9
Comprehensive Income0.1-2.0-3.5-3.7-3.3-4.4-2.8-4.7-5.7-4.7
Total Common Equity178.9183.0185.9186.8196.6205.6218.7401.2427.8378.3
Other TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Debt5.90.04.749.833.820.040.8136.593.7105.9134.3147.6159.0151.7150.06.66.8
Book Value205.6183.0205.6378.3424.5439.5455.9614.8542.6517.0507.0545.0537.9526.8523.4405.7391.3
Other 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value178.9183.0185.9186.8196.6205.6218.7401.2427.8378.3
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-184.3-34.0-184.3-52.4-26.5-31.5-165.861.316.37.0-44.5-3.33.1-0.6-5.18.112.3
Depreciation & Amortization27.725.827.730.929.325.923.825.923.224.828.430.525.129.113.012.612.5
Stock-Based Compensation10.59.810.511.210.78.67.69.27.96.23.26.05.44.64.14.64.9
Change Working Capital14.4-14.114.4-7.0-21.09.1-28.5-1.32.522.913.0-10.9-10.0-7.3-2.23.85.9
Change In Accounts Receivable7.90.07.9-1.3-17.2-4.211.9-3.25.08.53.12.1-14.91.0-2.52.8-2.6
Change In Accounts Payable27.5-15.927.52.13.94.9-15.25.2-7.117.2-3.4-5.97.3-12.76.7-2.45.6
Change In Inventories-9.4-1.3-9.4-8.2-2.811.5-18.8-1.45.70.712.0-6.2-5.4-2.4-1.11.68.3
Other Non-cash Items113.33.4111.519.84.116.8150.0-55.10.4-9.55.39.1-1.40.81.65.6-1.5
Cash from Operations-28.20.00.00.1-7.224.1-14.637.441.355.745.226.225.326.310.833.940.0
Cash Flow From Operating Activities 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Net Income-6.4-10.9-6.1-4.4-10.7-12.8-13.4-187.7-29.045.9
Depreciation & Amortization5.86.05.86.36.96.86.87.56.76.7
Stock-Based Compensation2.94.51.62.42.53.21.92.61.94.1
Change Working Capital1.6-16.316.7-18.03.3-16.19.718.88.0-22.1
Change In Accounts Receivable-1.60.10.4-0.5-3.73.85.51.7-2.53.2
Change In Accounts Payable3.2-10.72.6-11.07.5-15.010.817.715.6-16.5
Change In Inventories-3.3-0.21.12.8-1.3-4.1-2.62.0-4.3-4.6
Other Non-cash Items0.80.80.80.80.81.00.8158.41.4-49.1
Cash from Operations0.00.00.00.00.00.00.00.00.00.0
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-10.8-4.5-2.5-4.4-4.3-13.7-7.6-3.1-3.7-3.0-5.6-13.3-11.8-11.5-2.5-4.0-10.5
Acquisitions0.00.00.00.0-3.60.0-55.8-84.90.00.0-3.30.0-4.2-25.3-237.2-1.1-17.1
Investments0.00.00.00.00.00.00.00.00.00.0-2.00.00.0-5.1-5.0-44.4-1.3
Sales of Investment0.00.00.00.00.00.00.01.40.00.50.00.00.311.970.5124.141.1
Other Investing Activities0.00.00.0-5.4-11.40.00.0169.20.00.03.30.0-1.48.4-1.5-123.2-24.0
Cash from Investing123.70.00.0-9.7-19.3-13.7-63.382.6-3.7-2.6-7.6-13.3-17.0-21.6-175.7-48.6-11.8
Cash Flow From Investing Activities 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Capital Expenditure-0.4-0.7-0.8-1.8-0.8-1.1-0.6-0.6-0.6-0.8
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Investing0.00.00.00.00.00.00.00.00.00.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-100.00.00.025.00.0-20.0-132.5-15.0-5.0-140.4-16.3-20.0-146.3-7.5-6.6-0.3-0.3
Debt Issued56.1-4.7-45.141.013.8-0.836.857.8-7.2112.03.08.6153.59.2150.00.07.1
Issuance of Common Stock0.00.00.01.22.70.00.00.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.0-1.70.00.00.00.00.00.00.0-13.60.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-14.30.00.00.45.03.037.348.9-6.6116.0-7.49.5132.21.2148.92.23.0
Cash from Financing-64.20.00.025.47.7-17.0-95.233.9-11.6-38.0-23.7-10.5-14.0-6.3142.31.92.7
Cash Flow From Financing Activities 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued0.00.0-5.00.00.20.14.70.0-4.7-45.1
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.00.00.00.0-1.1-0.60.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Financing0.00.00.00.00.00.00.00.00.00.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash31.4-20.231.415.8-19.3-6.3-173.2153.526.615.213.92.3-5.7-1.7-22.5-12.830.9
Closing Cash Balance76.155.976.144.628.848.254.4227.674.147.532.318.416.121.823.546.058.8
Cash position 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Net Change in Cash2.9-17.111.1-9.3-0.9-21.1-2.417.63.313.0
Closing Cash Balance41.638.855.944.854.155.076.178.560.957.6
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-38.9-14.6-33.9-4.3-11.510.4-22.134.337.652.739.612.913.514.88.329.829.5
Real Free Cash Flow-49.5-24.4-44.5-15.4-22.21.8-29.725.129.746.636.47.08.110.24.225.224.6
Free Cash Flow 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Free Cash Flow4.2-16.618.0-15.01.7-19.34.4-16.44.7-26.7
Real Free Cash Flow1.3-21.116.4-17.4-0.9-22.62.5-19.02.8-30.8
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-15.6-31.51703.4
P/S1.41.867.9
P/B2.41.225.8
P/FCF-20.878.6396.3
Market cap$0.5$0.4
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %9.7 %0 %
Debt to Income0 %-1377.8 %0 %
Debt to Free cash flow0 %44.6 %0 %
Interest expense percentage-0.4 %1.6 %38.7 %
Current ratio2.3 3.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-15.5 %-10.2 %0 %
ROA-10.4 %-6.9 %0 %
CapEx to Revenue1.2 %2.4 %10.6 %
RaD to Revenue0 %8.6 %0 %
ROEM455,268.1 296735.8

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin53.7 %52.9 %79.8 %
Operating margin-9.4 %-3.7 %29.6 %
Net margin-9 %-9.1 %27.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding41.4 mil 35.5 mil
Employee count0.7 tis 0.8 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader